CollPlant Biotechnologies (CLGN) Free Cash Flow (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Free Cash Flow of -$2.9 million for Q4 2025, down 1.53% on a QoQ basis from -$2.9 million in Q3 2025, and up 14.24% year-over-year from -$2.6 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Free Cash Flow (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Free Cash Flow history runs 8 years deep, the most recent figure standing at -$2.9 million for Q4 2025.
- Quarterly Free Cash Flow rose 14.24% year-over-year to -$2.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$8.2 million (up 21.13% YoY) and the FY2025 annual result came in at -$9.4 million, up 31.0% from the prior year.
- Free Cash Flow was -$2.9 million for Q4 2025 at CollPlant Biotechnologies, down from -$2.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $11.2 million in Q1 2021 and bottomed at -$12.4 million in Q4 2022.
- A 5-year average of -$2.1 million and a median of -$2.9 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2021 — Free Cash Flow jumped 549.64% — and 2022, when it plunged 1152.42%.
- CollPlant Biotechnologies' Free Cash Flow stood at -$992000.0 in 2021, then plunged by 1152.42% to -$12.4 million in 2022, then soared by 82.97% to -$2.1 million in 2023, then tumbled by 60.92% to -$3.4 million in 2024, then increased by 14.24% to -$2.9 million in 2025.
- Business Quant data shows CLGN's Free Cash Flow at -$2.9 million in Q4 2025, -$2.9 million in Q3 2025, and -$2.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.95 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.92 Mn |
| Dec 31, 2025 | -2.92 Mn |
| Sep 30, 2025 | -2.88 Mn |
| Sep 30, 2025 | -2.88 Mn |
| Jun 30, 2025 | -2.44 Mn |
| Jun 30, 2025 | -2.44 Mn |
| Dec 31, 2024 | -3.41 Mn |
| Dec 31, 2024 | -3.41 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | -3.73 Mn |
| Jun 30, 2024 | -3.73 Mn |
| Mar 31, 2024 | -3.17 Mn |
| Mar 31, 2024 | -3.17 Mn |
| Dec 31, 2023 | -2.12 Mn |
| Dec 31, 2023 | -2.12 Mn |
| Sep 30, 2023 | 7.02 Mn |
| Sep 30, 2023 | 7.02 Mn |
| Jun 30, 2023 | -3.41 Mn |
| Jun 30, 2023 | -3.41 Mn |